[
    "{\"step_by_step_thinking\": \"Ivosidenib is a targeted therapy that inhibits the isocitrate dehydrogenase-1 (IDH1) enzyme. This enzyme is often mutated in certain types of cancer, including acute myeloid leukemia (AML). The FDA approval of a drug is based on clinical trials that demonstrate its safety and efficacy. I remember that ivosidenib has been approved by the FDA for the treatment of AML with a specific IDH1 mutation.\", \"answer_choice\": \"A\"}"
]